White House chief medical advisor Dr. Anthony Fauci to step down in December after more than 50 years of public service

White House chief medical advisor Dr. Anthony Fauci to step down in December after more than 50 years of public service


Dr. Anthony Fauci speaks about the Omicron coronavirus variant during a press briefing at the White House in Washington, December 1, 2021.

Kevin Lamarque | Reuters

The nation’s top infectious disease expert, Dr. Anthony Fauci, plans to step down from his roles running the National Institute of Allergy and Infectious Diseases and advising the White House as its chief medical advisor at the end of the year, he announced Monday.

Fauci has become a household fixture during the Covid-19 pandemic, battling back misinformation — sometimes from the highest levels of government. His steadfast commitment to science, challenging former President Donald Trump on everything from the use of  hydroxychloroquine to mask mandates, made him a quasi-celebrity in the process.

The 81-year-old has advised seven U.S. presidents, starting with Ronald Reagan through the HIV/AIDS epidemic, West Nile virus, the 2001 anthrax attacks, pandemic influenza, various bird influenza threats, Ebola, Zika and, most recently, Covid and monkeypox.

Fauci, who also runs the NIAID Laboratory of Immunoregulation, said he has no intentions of retiring.

“After more than 50 years of government service, I plan to pursue the next phase of my career while I still have so much energy and passion for my field,” Fauci said in a statement. “I want to use what I have learned as NIAID Director to continue to advance science and public health and to inspire and mentor the next generation of scientific leaders as they help prepare the world to face future infectious disease threats.”

He first joined the National Institutes of Health in 1968 at age 27 where he quickly rose through the ranks and eventually took over as director of the National Institute of Allergy and Infectious Diseases in 1984.

Fauci didn’t shy away from conflict. His Senate hearings were often peppered with terse exchanges with members of Congress, particularly with Sen. Rand Paul, R-Ky., who he once accused of inciting death threats against him and his family.

“What happens when he gets out and accuses me of things that are completely untrue is that all of a sudden that kindles the crazies out there and I have threats upon my life, harassment of my family and my children with obscene phone calls, because people are lying about me,” Fauci told the Senate health committee at a January hearing.

This is breaking news. Please check back for updates.



Source

Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
Health

Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound

Cr | Istock | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Another potential competitor to blockbuster obesity treatments from Eli Lilly and Novo Nordisk just showed positive data – but this time, […]

Read More
FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says
Health

FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says

The Food and Drug Administration will consider drug affordability when granting companies new vouchers that speed up approvals of some treatments, the agency’s Commissioner Marty Makary told CNBC on Friday.  The FDA in June announced a national priority voucher plan that aims to cut drug review times to one-to-two months for companies it says are […]

Read More
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
Health

Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses

The Hers website arranged on a laptop in New York, US, on Wednesday, Feb. 12, 2025. Gabby Jones | Bloomberg | Getty Images Hims & Hers Health announced Wednesday it will offer generic semaglutide in Canada as Novo Nordisk‘s patent on its branded drugs Ozempic and Wegovy is set to expire in January. “Canada is […]

Read More